Bank OZK Sells 2,345 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bank OZK lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 36.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,107 shares of the exchange traded fund’s stock after selling 2,345 shares during the period. Bank OZK’s holdings in SPDR S&P Biotech ETF were worth $367,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of XBI. Commonwealth Equity Services LLC lifted its position in SPDR S&P Biotech ETF by 58.1% during the third quarter. Commonwealth Equity Services LLC now owns 195,033 shares of the exchange traded fund’s stock valued at $14,241,000 after purchasing an additional 71,658 shares in the last quarter. Compagnie Lombard Odier SCmA lifted its position in SPDR S&P Biotech ETF by 417.4% during the third quarter. Compagnie Lombard Odier SCmA now owns 2,975 shares of the exchange traded fund’s stock valued at $217,000 after purchasing an additional 2,400 shares in the last quarter. Sheets Smith Wealth Management purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at $55,000. Deltec Asset Management LLC lifted its position in SPDR S&P Biotech ETF by 28.4% during the third quarter. Deltec Asset Management LLC now owns 36,200 shares of the exchange traded fund’s stock valued at $2,643,000 after purchasing an additional 8,000 shares in the last quarter. Finally, AFG Fiduciary Services Limited Partnership lifted its position in SPDR S&P Biotech ETF by 12.5% during the third quarter. AFG Fiduciary Services Limited Partnership now owns 9,171 shares of the exchange traded fund’s stock valued at $638,000 after purchasing an additional 1,019 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.5 %

NYSEARCA XBI traded up $1.27 on Friday, hitting $83.49. 10,452,779 shares of the company traded hands, compared to its average volume of 11,723,970. The company has a market capitalization of $6.49 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. The business’s 50 day moving average price is $92.69 and its 200-day moving average price is $84.72. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.